Urokinase Recombinant Rabbit Monoclonal Antibody ET1703-26 from HUABIO | Biocompare.com

Published Figures

Register or Sign In to View Figures.

Scientific Reports
November 27 2022

Fig 1: On the basis of the HPA database, the protein expression levels of CSRP2, CAV1, APP, TNFRSF12A, CAV2, PLAU, and LAMC2 were significantly higher in HNSCC tumor tissues than in normal tissues, whereas the protein expression levels of HMGA1, PRAME, and AREG were not significantly different between normal and tumor tissues.
Register or Sign In to View Figures.

Scientific Reports
November 27 2022

Fig 2: The mRNA and protein expression levels of PLAU, APP, AREG and CAV2 were upregulated in cancer cells compared to normal cells.

Be the first to write a review!

Citations:

Figures:

Supplier Page from
HUABIO for
Urokinase Recombinant Rabbit Monoclonal Antibody

The Urokinase Recombinant Rabbit Monoclonal Antibody from HUABIO is a Rabbit Monoclonal antibody to Plau. This antibody recognizes Human, Mouse, and Rat antigen. The Urokinase Recombinant Rabbit Monoclonal Antibody has been validated for the following applications: Immunohistochemistry, Immunohistochemistry - fixed, and Western Blot.

Product Specs
ItemUrokinase Recombinant Rabbit Monoclonal Antibody
CompanyHUABIO
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberET1703-26
Quantity1
ApplicationsWB,IHC-P
Conjugate/Tagunconjugated
Format1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide
PurityProtein A affinity purified
ReactivityHuman,Mouse,Rat
IsotypeIgG
CloneJM106-09
HostRabbit
NCBI Gene AliasesATF, BDPLT5, QPD, UPA, URK, u-PA
Clonalitymonoclonal
Volume100ul
Concentration1ug/ul
TargetUrokinase
Molecular Weight49 kDa
Gene NamePLAU
ImmunogenSynthetic peptide within Human Urokinase aa 50-99 / 431
NCBI Full Gene Nameplasminogen activator, urokinase
Brand/TrademarkHUABIO

Add to Compare List

HUABIO

HUABIO

300 Tradecenter

Woburn, MA 01801

United States

Phone: +1 857-353-6600
Fax: +1 857-353-6500

Email: support@huabio.com

Company Profile

Website: www.huabio.com

(1) Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectoriesScientific ReportsNovember 27, 2022Ji Yin, Sihan Zheng, Xinling He, Yanlin Huang, Lanxin Hu, Fengfeng Qin, Lunkun Zhong, Sen Li, Wenjian Hu, Jiali Zhumembranes were probed with antibodies anti-Amphigireegulin, ER1903-67; anti-Urokinase Recombinant, ET1703-26, anti-Amyloid Beta A4 Precursor(APP), 1007–5; anti-Caveolin-2, ET1607-15 (HUABIO, Hangzhou, China) as

Be the First to Write a Review!